Riskpilot← Back to searchSign inGet full accessAB Doktor Fniss
ABActiveOrg 5569273393Hillebardsgränden 4Activities of performing arts · NACE 9020Est. 20130 employees
Revenue 2025
SEK 2,4M
+12% vs 2024
EBITDA margin
71.3%
-10% vs 2024
Equity ratio
89.3%
Financial strength
Net profit 2025
SEK 1,3M
-14% vs 2024
| Revenue | SEK 2,4M | +12% |
| EBITDA | SEK 1,7M | -10% |
| Net profit | SEK 1,3M | -14% |
| Total assets | SEK 4,8M | +25% |
| Equity | SEK 4,3M | +32% |
| Employees | 0 | — |
Legal name
AB Doktor Fniss
Org number
5569273393
Legal form
Aktiebolag
NACE code
9020 · Activities of performing arts
Founded
2 april 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva artistisk-, litterär-, konstnärlig-, samt musik- och videoproduktion. Bolaget skall även bedriva hälso- och sjukvård samt handel med värdepapper och därmed förenlig verksamhet.
Address
Hillebardsgränden 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 871 | 1 787 | 2 211 | 2 147 | 2 405 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 294 | 1 505 | 1 561 | 1 894 | 1 714 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 294 | 1 505 | 1 561 | 1 894 | 1 714 |
| Net financials | — | 0 | 5 | 4 | −59 |
| Profit before tax | 294 | 1 505 | 1 566 | 1 897 | 1 655 |
| Tax | −61 | −312 | −323 | −392 | −368 |
| Net profit | 233 | 1 194 | 1 242 | 1 505 | 1 287 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 736 | 2 162 | 2 881 | 3 848 | 4 828 |
| Equity | 520 | 1 613 | 2 105 | 3 261 | 4 313 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 216 | 549 | 776 | 588 | 515 |
| Total debt | 216 | 549 | 776 | 588 | 515 |
EBITDA margin
71.3%
This company
15.8%
Market median
+351% vs market
20212025
Equity ratio
89.3%
This company
38.2%
Market median
+134% vs market
20212025
Return on equity
29.8%
This company
18.4%
Market median
+62% vs market
20212025
Net profit margin
53.5%
This company
8.1%
Market median
+560% vs market
20212025
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
20212025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AB Doktor Fniss also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jessica Cecilia Petri Widegren | Deputy Board Member | 0 companies |
| Henrik Daniel Widegren | Board of Directors | 0 companies |